<?xml version="1.0" encoding="UTF-8"?>
<!-- Dublin Core rendering of 16652e25-1204-4d55-910b-9df5fd952f80, generated by folio-assistant-core/scripts/dc-render.ts. Do not edit. -->
<!-- not expressible as DC XML (no DCMI element): who.relation.languageVersion -->
<metadata xmlns="https://litlfred.github.io/folio-assistant-core/v0/ns/dspace/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <dcterms:creator xml:lang="en-US">World Health Organization</dcterms:creator>
  <dcterms:spatial xml:lang="en-US">Geneva</dcterms:spatial>
  <dc:date>2021-07-06T05:40:20Z</dc:date> <!-- dc.date.accessioned -->
  <dcterms:available xsi:type="dcterms:W3CDTF">2021-07-06T05:40:20Z</dcterms:available>
  <dcterms:issued xsi:type="dcterms:W3CDTF">2021-07-06</dcterms:issued>
  <dcterms:description xml:lang="en-US">xvi, 97 p.</dcterms:description>
  <dcterms:description>The Spanish version published by PAHO: https://iris.paho.org/handle/10665.2/62990</dcterms:description>
  <dcterms:abstract>This second edition of the WHO guideline provides updated evidence-based recommendations for screening and treatment of cervical pre-cancer lesions to prevent cervical cancer in both the general population of women and women living with HIV. Developed in support of the WHO global strategy to eliminate cervical cancer as a public health problem, the guideline responds to advances in screening technologies and implementation approaches by updating previous recommendations and introducing new guidance to simplify clinical algorithms while improving feasibility, acceptability and programme performance across diverse health system settings. The recommendations were developed in accordance with WHO guideline development procedures using systematic reviews, mathematical modelling where necessary, GRADE assessments of the certainty of evidence, evidence-to-decision frameworks, and consideration of feasibility, costs, acceptability and users’ values and preferences.

The guideline presents recommendations and good practice statements on primary screening tests, screening intervals, age at initiation and cessation of screening, triage strategies, follow-up after positive screening results, treatment approaches, and programme implementation for both population groups. It addresses service delivery, integration with HIV care, implementation considerations, research gaps and dissemination, while emphasizing the transition to HPV DNA testing, the use of evidence-based screening and treatment algorithms, and country adaptation according to available resources and local context to improve coverage, quality of care and cervical cancer prevention.</dcterms:abstract>
  <dc:identifier>9789240030824 (electronic version)</dc:identifier> <!-- dc.identifier.isbn -->
  <dc:identifier>9789240030831 (print version)</dc:identifier> <!-- dc.identifier.isbn -->
  <dcterms:identifier xsi:type="dcterms:URI">https://iris.who.int/handle/10665/342365</dcterms:identifier>
  <dcterms:language>English</dcterms:language>
  <dcterms:language>Español</dcterms:language>
  <dcterms:language xsi:type="dcterms:RFC4646" xml:lang="en-US">en</dcterms:language>
  <dcterms:language xsi:type="dcterms:RFC4646">es</dcterms:language>
  <dcterms:publisher xml:lang="en-US">World Health Organization</dcterms:publisher>
  <dcterms:relation>Related document (Policy brief, Web annexes A-B):</dcterms:relation>
  <dcterms:relation>https://iris.who.int/handle/10665/342712</dcterms:relation>
  <dcterms:relation>https://iris.who.int/handle/10665/342366</dcterms:relation>
  <dcterms:relation>https://iris.who.int/handle/10665/342367</dcterms:relation>
  <dc:relation>https://iris.who.int/handle/10665/342366</dc:relation> <!-- dc.relation.haspart -->
  <dc:relation>https://iris.who.int/handle/10665/342367</dc:relation> <!-- dc.relation.haspart -->
  <dc:relation>https://iris.who.int/handle/10665/342712</dc:relation> <!-- dc.relation.hasversion -->
  <dcterms:rights xml:lang="en-US">CC BY-NC-SA 3.0 IGO</dcterms:rights>
  <dc:rights xml:lang="en-US">World Health Organization</dc:rights> <!-- dc.rights.holder -->
  <dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc-sa/3.0/igo</dc:rights> <!-- dc.rights.uri -->
  <dcterms:subject xml:lang="en-US">WHO guideline</dcterms:subject>
  <dcterms:subject xsi:type="dcterms:MESH" xml:lang="en-US">Uterine Cervical Neoplasms</dcterms:subject>
  <dcterms:subject xsi:type="dcterms:MESH" xml:lang="en-US">Precancerous Conditions</dcterms:subject>
  <dcterms:subject xsi:type="dcterms:MESH" xml:lang="en-US">Guideline</dcterms:subject>
  <dc:subject xml:lang="en-US">prevention and control</dc:subject> <!-- dc.subject.meshqualifier -->
  <dc:subject xml:lang="en-US">diagnosis</dc:subject> <!-- dc.subject.meshqualifier -->
  <dc:subject xml:lang="en-US">therapy</dc:subject> <!-- dc.subject.meshqualifier -->
  <dcterms:title xml:lang="en-US">WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention</dcterms:title>
  <dc:title xml:lang="en-US">2nd ed</dc:title> <!-- dc.title.release -->
  <dcterms:type xml:lang="en-US">Publications</dcterms:type>
</metadata>
